Tandem Diabetes Care Quarterly Balance Sheet
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Tandem Diabetes Care financial position
As of Jun 30, 2026, Tandem Diabetes Care reported total assets of $1.15 billion, up 31.8% from a year earlier against total liabilities of $1.02 billion. Shareholders' equity stood at $130.4 million, or 11.3% of assets. The company held $62.8 million in cash and equivalents against $602.6 million of debt, a net debt position of $539.8 million.
The current ratio (current assets divided by current liabilities) was 3.18, meaning short-term assets cover obligations due within a year. Debt-to-equity was 4.62.
Summary generated from market data by MetaCap's automated system. Methodology
Tandem Diabetes Care balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 62.82M | 179.32M | 90.63M | 91.95M | 64.11M | 53.57M | 69.23M | 49.04M | 47.70M | 58.98M | 58.87M | 79.61M |
| Short-Term Investments | 393.18M | 390.93M | 202.03M | 227.16M | 251.25M | 315.05M | 369.10M | 424.27M | 404.72M | 408.83M | 409.04M | 418.55M |
| Receivables | 162.06M | 140.67M | 165.49M | 125.94M | 128.44M | 126.56M | 114.58M | 107.19M | 98.12M | 92.97M | 105.56M | 100.32M |
| Inventory | 135.11M | 126.40M | 128.77M | 137.28M | 142.57M | 141.16M | 149.61M | 152.44M | 161.66M | 153.89M | 157.94M | 143.49M |
| Total Current Assets | 804.64M | 887.10M | 618.14M | 616.94M | 614.82M | 663.43M | 724.49M | 752.83M | 733.39M | 735.19M | 747.99M | 758.14M |
| Property, Plant & Equipment | 84.50M | 83.25M | 83.58M | 77.92M | 77.51M | 79.22M | 78.15M | 81.06M | 78.63M | 77.53M | 76.54M | 75.76M |
| Intangible Assets | — | — | 11.72M | — | — | — | 925.00K | — | — | — | 2.78M | — |
| Total Assets | 1.15B | 1.15B | 881.11M | 874.65M | 875.74M | 922.14M | 967.66M | 957.73M | 937.50M | 941.04M | 952.66M | 939.91M |
| Accounts Payable | 64.13M | 59.86M | 47.07M | 47.48M | 55.84M | 59.80M | 44.73M | 48.75M | 47.78M | 48.14M | 49.59M | 46.14M |
| Short-Term Debt | — | — | — | — | — | — | 40.67M | 40.60M | 40.54M | — | 0 | — |
| Total Current Liabilities | 253.00M | 247.96M | 242.72M | 252.54M | 251.69M | 288.18M | 247.05M | 259.28M | 240.61M | 192.97M | 195.26M | 187.11M |
| Long-Term Debt | 602.58M | 601.77M | 310.04M | 309.59M | 309.15M | 308.70M | 308.27M | 307.83M | 307.39M | — | 285.04M | — |
| Total Liabilities | 1.02B | 1.02B | 725.94M | 741.69M | 742.45M | 766.85M | 704.56M | 720.02M | 703.63M | 697.98M | 639.03M | 625.91M |
| Shareholders' Equity | 130.39M | 132.40M | 155.17M | 132.97M | 133.28M | 155.29M | 263.10M | 237.71M | 233.88M | 243.06M | 313.63M | 314.00M |
| Retained Earnings | -1.29B | -1.27B | -1.25B | -1.25B | -1.23B | -1.18B | -1.05B | -1.05B | -1.03B | -994.51M | -951.80M | -921.80M |
| Total Debt | 602.58M | 601.77M | 310.04M | 309.59M | 309.15M | 308.70M | 348.94M | 348.43M | 347.93M | — | 285.04M | — |
| Net Cash (Debt) | -146.58M | -31.51M | -17.37M | 9.52M | 6.21M | 59.92M | 89.39M | 124.87M | 104.48M | 467.81M | 182.88M | 498.16M |
| Shares Outstanding | 69.54M | 68.50M | 68.29M | 67.77M | 67.53M | 66.57M | 66.26M | 65.65M | 65.44M | 64.56M | 65.55M | 65.19M |
This table shows 12 quarterly periods of Tandem Diabetes Care's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TNDM's reporting calendar. What is a balance sheet?